Direct Answer
115 SEC filers are classified under the Standard Industrial Classification codes that describe the medical devices industry, and their latest annual reports show $252.3 billion of combined revenue and a median operating margin of -22.3%. Investors should still evaluate its revenue model, industry-specific KPIs, valuation framework and the risks that can change the group's economics.
Industry Overview
Medical device makers design and sell products used in diagnosis, surgery and treatment, from implants and monitors to surgical tools. Innovation, clinical evidence and hospital purchasing decisions drive growth. The first numbers to compare across companies here are organic growth by franchise, gross margin and procedure volumes.
Key Industry Metrics
- Organic growth by franchise: Sales growth excluding acquisitions and currency, by product family. It shows which franchises are driving growth and which are lagging.
- Gross margin: Share of sales left after cost of making devices. It reflects pricing power, mix and manufacturing scale, and can fall with recalls or price cuts.
- Procedure volumes: Number of procedures in which products are used. Device demand follows procedures, so strong volumes support sales.
- Share of recurring consumables: Portion of revenue from disposables and supplies used with each procedure. A higher share makes revenue steadier than capital equipment sales.
- R&D investment and launches: Spending on new products and the pace of introductions. It supports future share, but returns depend on clinical adoption.
Primary Macro Drivers
- Aging population and procedure growth: Older people need more joint, heart and eye procedures, so population aging supports procedure volumes and organic growth.
- Reimbursement and coverage: Insurer and Medicare coverage decides which devices can be paid for, which affects procedure volumes and pricing.
- Innovation cycles: New products and improvements can win share and support higher prices, so launches and trial data drive growth in a franchise.
- Hospital capital spending: Hospitals buy capital equipment out of budgets, so tight finances delay orders for monitors, robots and imaging systems.
Major Risks
- Recalls and regulatory action: A recall or regulator action can halt sales, cost money and hurt trust; watch recall notices and warning letters.
- Pricing pressure: Hospitals and buying groups push for lower prices, which narrows gross margin; watch pricing commentary and organic growth.
- Competition: Rivals with better data or lower prices can take share in a franchise; watch share trends and launch timing.
- Reimbursement changes: Lower payments for a procedure can slow volume or shift use to other devices; watch payment rule proposals.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Mixed |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. / Global |
Medical Devices Filers in the SEC Record
115 companies with annual reports in the dataset are classified by the SEC in the Standard Industrial Classification codes 3841, 3842, 3845, 3851. Their latest fiscal years end between 2022 and 2026, and together they reported $252.3 billion of revenue. Median revenue growth over the prior year was 13.3%. Median operating margin was -22.3% and median net margin -18.8%. Median total liabilities were 46% of total assets, and 40 of 115 reported a profit in their latest year.
| Company | Revenue | Growth | Operating margin | Net margin | Year |
|---|---|---|---|---|---|
| Medtronic Plc | $36.4 billion | 8.4% | 17.8% | 0.0% | FY 2026 |
| Medline Inc. | $28.4 billion | 11.5% | 7.8% | 4069.4% | FY 2025 |
| Stryker Corp | $25.1 billion | 11.2% | 19.5% | 12.9% | FY 2025 |
| 3m Co | $24.9 billion | 1.5% | 18.6% | 13.0% | FY 2025 |
| Becton Dickinson & Co | $21.8 billion | 8.2% | 11.8% | 7.7% | FY 2025 |
| Boston Scientific Corp | $20.1 billion | 19.9% | 18.0% | 14.4% | FY 2025 |
| Baxter International Inc | $11.2 billion | 5.7% | -2.7% | -8.5% | FY 2025 |
| Intuitive Surgical Inc | $10.1 billion | 20.5% | 29.3% | 28.4% | FY 2025 |
The 8 largest of 115 by revenue. Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. A company's SIC code reflects its main business as the SEC records it, so it can differ from how an index provider or analyst classifies the company, and a diversified group appears under only one code.
Where to Go Next
The Medical Devices guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Medical Imaging Equipment
- Medicaid Managed Care
- Medical Supplies
- Managed Health Care
- Medicare Advantage
- Managed Care
- Metabolic Disease Biotechnology
- Life Sciences Tools & Services
Put it to work
Frequently Asked Questions
What are the main KPIs for the Medical Devices industry?
Key performance indicators for the Medical Devices industry include: Organic growth by franchise, Gross margin, Procedure volumes, Share of recurring consumables, R&D investment and launches. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Medical Devices industry?
The Medical Devices industry exhibits mixed cyclicality characteristics. Some segments move with the broader economy while others maintain more stable demand, making stock selection within the group particularly important.
What are the biggest risks in the Medical Devices industry?
The primary risks for Medical Devices companies include: Recalls and regulatory action, Pricing pressure, Competition, Reimbursement changes. Investors should assess each company's exposure to these factors and its track record of navigating them.